Immune Related Adverse Event Management :: UK Acute Oncology Society

Acute Oncology Guidelines

There are a number of types of immunotherapy
Immunotherapy is now recognised as one of the standard treatment modalities against cancer along with surgery, radiotherapy and chemotherapy.
Cancer immunotherapy activates the individuals own immune system to attack cancer cells , aiming at mounting an effective antitumour immune response.

Are you a health professional looking for immediate guidance?

UKONS Acute Oncology Initial Management Guidelines may help

National and International Guidelines

Society for Endocrinology Endocrine Emergency Guidance: Acute management of the endocrine complications of checkpoint inhibitor therapy
European Society for Medical Oncology (ESMO) - Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO Management of toxicities from immunotherapy - slide set PDF
National Institute for Health and Care Excellence - NICE
ASCO Clinical Practice Guideline: Management of Immune-Related Adverse Events From Immune Checkpoint Inhibitor Therapy
Multinational Association of Supportive Care in Cancer (MASCC) 2020 Clinical Practice Recommendations for the Management of Immune-mediated Adverse Events from Checkpoint Inhibitors

Youtube - Beyond Checkpoint Blockade for Cancer Immunotherapy

Youtube - Nature | Cancer Immunotherapy - medical animation.

An-Liang Xia,Yong Xu, Xiao-Jie Lu Cancer immunotherapy: challenges and clinical applications -http://dx.doi.org/10.1136/jmedgenet-2018-105852

We are eager to develop the content of this page and would be pleased to accept contributions and suggestions, please contact us if you are able to help

Please note that you should always assume that the website group, society and authors /owners of any of these documents links or guidance make no representations or guarantees as to the accuracy, completeness or adequacy of any of the content and make no warranties express implied or otherwise and cannot be held responsible for any liability, loss or damage whatsoever caused by the use of the content. You should always act within the limits of your competence and seek senior advice or support where appropriate.

Are you a health professional looking for immediate guidance?

UKONS Acute Oncology Initial Management Guidelines may help

National and International Guidelines

The UK Acute Oncology Society (UKAOS) is most grateful to Exact Sciences and Pfizer for their joint funding support of the Society in its inaugural year; the support from Pfizer was in the form of an unrestricted educational grant. The companies have had no influence on the set up of UKAOS.